Global Life Science Leader [ ]
BGI’s unparalleled understanding of its clients’ competitive landscape in conjunction with best-in-class executive through board level recruiting makes it the search firm of choice with clients that are truly focused on driving their success and bringing exceptional shareholder value.
 CEO Board Executive Learn More Global Life Science Leader [ ] BGI’s unparalleled understanding of its clients’ competitive
landscape in conjunction with best-in-class executive
through board level recruiting makes it the search firm
of choice with clients that are truly focused on driving
their success and bringing exceptional shareholder value. Biotechnology Pharmaceutical Medical Device Contract Services Learn More Global Life Science Leader [ ] BGI’s unparalleled understanding of its clients’ competitive
landscape in conjunction with best-in-class executive
through board level recruiting makes it the search firm
of choice with clients that are truly focused on driving
their success and bringing exceptional shareholder value. Saving Lives Improving Treatments Learn More Maximizing Shareholder Value Finding Cures Helping Clients

Encompassing all Executive through Board Positions in Life Sciences

Director of the Board

Yes

Chief Executive Officer

Yes

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.

No

Chairman of the Board

Yes

Chief Financial Officer

Formerly Aastrom Biosciences

Yes

Chief Operating Officer

Yes

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company

No

Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.

Yes
See More

In The News

Facing drug pricing pressure from the U.S., Belgium, the Netherlands, Luxembourg, Austria and Ireland stressed the need for “collaborative efforts across the Union” in a June 10 statement.

https://www.fiercepharma.com/pharma/joint-initiative-5-eu-countries-calls-unified-approach-pharma-framework-amid-us-drug-pricing

Madrigal Pharmaceuticals has installed a 20-foot-tall, 41-foot-wide inflatable liver in a Philadelphia park to mark Global Fatty Liver Awareness Day.

https://www.fiercepharma.com/marketing/madrigal-takes-giant-inflatable-liver-us-tour-disease-awareness-push

Takeda has won the battle of the TYK2 inhibitors, toppling Bristol Myers Squibb’s Sotyktu to strengthen its hand ahead of an anticipated plaque psoriasis launch next year.

https://www.fiercepharma.com/biotech/takedas-tyk2-inhibitor-beats-bristol-myers-sotyktu-psoriasis-showdown

The Crohn’s & Colitis Foundation has tapped agency Olixir NY for its new inflammatory bowel disease public service announcement.

https://www.fiercepharma.com/marketing/olixir-ny-teams-crohns-colitis-foundation-its-spill-your-guts-campaign

The CEO voiced his concerns about Germany’s new healthcare reform plan in a letter to Chancellor Friedrich Merz, according to reports.

https://www.fiercepharma.com/pharma/amid-growing-industry-backlash-germanys-healthcare-reform-plan-pfizer-ceo-bourla-re

Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma.

https://www.fiercepharma.com/biotech/big-pharma-backed-sonothera-sounds-125m-series-b-bubble-based-genetic-delivery

Piper Sandler Spring Biopharma Symposium
Boston, MA April 15-16

Needham & Co. Annual Healthcare Conference
New York, NY April 13-16

Society of Gynecologic Oncology Annual Meeting (SGO)
San Juan, Puerto Rico April 11-13

American Academy of Dermatology (AAD)
Denver, CO March 27-30

Society of Toxicology Annual Meeting (SOT)
San Diego, CA March 22-26

American Society of Clinical Oncology Genitourinary Cancers Symposium
San Francisco, CA February 26-28

See More Events

Read More Articles